Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized double-blind active-controlled trial of an adsorbed tetanus vaccine in adults
CTR20233525Phase 3Completed
- Sponsor
- CanSino Biologics Inc.
- Start
- Nov 2023
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of tetanus toxoid in Tetanus, sponsored by CanSino Biologics Inc.. Started Nov 2023; status: completed.
02
Drugs
tetanus toxoid
03
Conditions
Tetanus
Beyond the preview
Go deeper on CTR20233525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20233525.